Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : TATRADER GIZZARD STUDY--Stocks 12.00 or Less..... -- Ignore unavailable to you. Want to Upgrade?

To: Rick Dudley who wrote (25978)	11/26/2001 8:29:44 AM
From: JustTradeEm	Read Replies (1) \| Respond to of 59879

The embryo that was cloned was done not for reproducing humans but to develop new stem cell lines. The government will not fund development of new stem cell lines. Since the company cloning the embryo is privately funded, there are no government restrictions. Development of new stem cell lines would aid development of new treatments for many diseases. JB

To: Rick Dudley who wrote (25978)	11/26/2001 12:33:48 PM
From: NW_Trader	Respond to of 59879

Hi Rick, Yes, they have had some interesting volume the past couple weeks - think it has to do with the news that a private co. has cloned human embryos for stem cell research. Stem cell news will move these and GERN, CCEL, and others. However, I'm not expecting much at this point of the year - probably too many holders from earlier that would just love to cut their losses. BWDIK. I do have long term holdings in STEM, but dumped ASTM long time back - I've become adverse to < $1 stocks until the small caps and the general markets get a lot healthier (or irrationally exuberant <VBG>). Peace and Justice --- Patrick